Meriwether Wealth & Planning, LLC Abb Vie Inc. Transaction History
Meriwether Wealth & Planning, LLC
- $140 Billion
- Q4 2024
A detailed history of Meriwether Wealth & Planning, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Meriwether Wealth & Planning, LLC holds 2,940 shares of ABBV stock, worth $560,364. This represents 0.37% of its overall portfolio holdings.
Number of Shares
2,940Holding current value
$560,364% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,927Shares Held
1.26BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$32.7 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$26 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15.1 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.97 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.38 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $337B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...